Industries
Nuclear Fuel Cycle
All research in Nuclear Fuel Cycle — 6 reports.
42/100
Silex Systems: A Scarce Enrichment Option Priced for Commercial Success It Has Yet to Earn
Silex Systems is not a uranium miner but a technology-commercialisation vehicle whose value rests on the SILEX laser enrichment process and a 51% stake in Global Laser Enrichment, the scarce listed proxy for rebuilding Western uranium-enrichment capacity. October 2025's independently validated TRL-6 milestone and U.S. policy support are real, yet the parent still burns negative owner earnings after roughly A$36m of annual GLE funding, and at A$4.50 the shares already trade above the A$3.70 conservative fair value. Rating Hold: genuine technical and policy progress, but the stock prices in a large amount of licensing and commercialisation success before it is earned.
40/100
Paladin Energy: The Restart Is Working, and the Price Already Knows It
Paladin Energy is an Australian-listed uranium miner whose cash engine is the 75%-owned Langer Heinrich restart in Namibia, with Patterson Lake South in Saskatchewan as a later-dated growth option targeting first production in 2031. March-2026 quarterly production reached 1.29 million pounds with plant recovery at 92%, prompting management to raise FY2026 guidance to 4.5-4.8 million pounds, yet the December-2025 half-year still showed a US$15.1 million statutory after-tax loss and PLS carries a US$1.226 billion pre-production capital estimate. Rating Hold: at A$9.18 the stock sits inside the acceptable-hold band of A$8.0-10.8, above the ideal buy zone of A$6.0-7.0, paying roughly fair value for a successful ramp plus meaningful PLS credit.
41/100
Energy Fuels: A Genuine Uranium Ramp, Priced Ahead of an Unbuilt Rare-Earth Chain
Energy Fuels operates White Mesa, the only fully licensed conventional uranium mill in the U.S., and is using that platform to move from uranium ore processing into rare-earth separation and critical-minerals feedstock through the Base, ASM, and VAC deals. 2025 revenue was just $65.9 million with an $85.6 million net loss, yet the stock trades at a $3.17 billion market cap that already prices in a mine-to-magnet chain still years from closing and commercializing. Rating Hold: the uranium ramp is real and improving, but at $12.67 the shares already bank future rare-earth and magnet success, leaving little margin of safety.
33/100
Uranium Energy Corp: Scarce U.S. Uranium Assets, Priced Ahead of the Proof
Uranium Energy Corp is a U.S. in-situ-recovery uranium miner running the country's only two active ISR production hubs, in Wyoming and South Texas, while building toward a domestic conversion business through its UR&C subsidiary. The balance sheet is genuinely strong, with $489.9 million in cash plus restricted cash and no debt as of April 2026, but five-year operating cash flow totaled roughly negative $192.8 million, 2025 revenue of $66.8 million still came mainly from selling purchased inventory rather than mined output, and shares outstanding rose from 378.5 million to 493.3 million since 2023. Rating Avoid: the licensed U.S. permits and policy tailwinds are real, but at $10.07 the stock already sits above even the report's optimistic per-share fair value of $9.02, leaving no margin of safety.
41/100
Kazatomprom (KAP.IL) Zen Horizon Deep-Dive Report
Kazatomprom is Kazakhstan's national atomic company and the world's largest uranium producer, supplying about 22% of global primary output while sitting at the low end of the cost curve through its ISL mining model. The core thesis is a rare combination of scale, cost leadership, and high dividends, offset by sulfuric acid inflation, state-control discounts, and China-Russia-linked geopolitical risk. Rating Watch: a durable uranium leader, but the current price offers a roughly balanced risk-reward rather than a clear margin of safety.
34/100
NuScale Power (SMR): Zen Horizon Research Report
NuScale Power is the world's first small modular reactor (SMR) pure-play to win a U.S. NRC-approved design certification, spun out of Oregon State University's IRIS project in 2007 and listed via SPAC in 2022; each SMR module is rated at 77 MWe and a typical multi-module plant runs 924 MWe. But the early-2024 cancellation of its flagship CFPP/UAMPS project gutted the commercial outlook, with TTM revenue of just $18.7M, Q1 revenue down 95.8% year over year, an operating margin of -101%, and a commercial deployment window no earlier than the 2030s. At the current $10.50 share price (down 70% over the past year), the implied 195x P/S still leaves valuation badly overextended. Rating Avoid: a compelling story is not a good investment, and the gap between narrative and fundamentals has reached an unsustainable level.